View in EDS

Regulatory issues in developing new HIV protease inhibitors: risks and benefits.

Saved in:
Bibliographic Details
Title: Regulatory issues in developing new HIV protease inhibitors: risks and benefits.
Authors: Struble KA; Office of New Drugs, Office of Antimicrobial Products, Division of Antiviral Products, US Food and Drug Administration, USA. Kimberly.struble@fda.hhs.gov, Chan-Tack KM, Soon GG
Source: Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2008 Nov; Vol. 3 (6), pp. 676-80.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101264945 Publication Model: Print Cited Medium: Internet ISSN: 1746-6318 (Electronic) Linking ISSN: 1746630X NLM ISO Abbreviation: Curr Opin HIV AIDS Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19373041
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Regulatory issues in developing new HIV protease inhibitors: risks and benefits.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Struble+KA%22">Struble KA</searchLink>; Office of New Drugs, Office of Antimicrobial Products, Division of Antiviral Products, US Food and Drug Administration, USA. Kimberly.struble@fda.hhs.gov<br /><searchLink fieldCode="AU" term="%22Chan-Tack+KM%22">Chan-Tack KM</searchLink><br /><searchLink fieldCode="AU" term="%22Soon+GG%22">Soon GG</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101264945%22">Current opinion in HIV and AIDS</searchLink> [Curr Opin HIV AIDS] 2008 Nov; Vol. 3 (6), pp. 676-80.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101264945 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1746-6318 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221746630X%22">1746630X </searchLink><i>NLM ISO Abbreviation: </i>Curr Opin HIV AIDS <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19373041
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/COH.0b013e3283136cb1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 676
    Titles:
      – TitleFull: Regulatory issues in developing new HIV protease inhibitors: risks and benefits.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Struble KA
      – PersonEntity:
          Name:
            NameFull: Chan-Tack KM
      – PersonEntity:
          Name:
            NameFull: Soon GG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2008 Nov
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-electronic
              Value: 1746-6318
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Current opinion in HIV and AIDS
              Type: main
ResultId 1